AVP of Safety and Transformation at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, HealthcareIndustries

Requirements

Transformational yet execution-focused leader capable of articulating compelling vision
Ability to build stakeholder confidence and navigate complex global organizations
Experience delivering measurable results in a highly regulated environment
Expertise in pharmaceutical innovation, drug development, patient safety, and pharmacovigilance
Knowledge of technology strategy, IT operating models, automation, AI, and advanced analytics
Experience leading service management transformation and organizational change
Strategic oversight in Asia R&D markets (China, Japan, Singapore) with ability to harmonize global and regional requirements
Capability to identify high-value AI use cases, guide proof-of-concepts, and scale innovations

Responsibilities

Lead enterprise strategy for drug safety technology systems and pharmacovigilance capabilities, including continuous modernization to meet regulatory and business needs
Drive service management transformation utilizing the Global Capability Center in India, including assessing/simplifying workflows, insourcing, and adopting automation/AI
Provide strategic direction, oversight, and execution for R&D technology teams in Asia (China, Japan, Singapore), ensuring harmonization with global innovation
Champion AI and advanced analytics integration across patient safety, pharmacovigilance, service management, and Asia R&D workflows and platforms
Define and execute multi-year technology strategies for patient safety, Asia R&D, and related domains aligned with corporate objectives and R&D priorities
Partner with senior R&D and business leaders to transform technology enabling patient safety and operational efficiency
Lead a high-performing global team with accountability across the US and key Asian markets
Balance strategic leadership with hands-on execution to deliver productivity, quality, speed improvements, and faster/safer delivery of medicines

Skills

Pharmacovigilance

Patient Safety

Technology Strategy

Service Management

Workflow Transformation

Global Capability Center

Drug Safety Systems

Regulatory Compliance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free